Kerry Group’s BC30 probiotic may improve digestive health for GLP-1 users, according to recent consumer perception study

While undergoing weight loss regimens, receiving the proper nutrition is especially important for individuals using glucagon-like peptide-1 (GLP-1) medications.

Recently the Kerry Group orchestrated a four-week, open-label, uncontrolled consumer perception study which sought to explore how their BC30 probiotic could help GLP-1 medication users.¹ The consumer perception study found:¹

• 77% of participants experienced improvement in their overall daily quality of life.
• 60% of participants said that their digestive health improved and 12% mentioned it as “game changer.”
• More than 80% of participants noticed an improvement in their GI symptoms compared to at baseline, symptoms either ceased or improved.
• 69% of participants reported their continued use of GLP-1 medications due to the probiotics benefits on their quality of life and digestive health.
• 66% stated they would buy BC30, 91% mentioned that they would recommend it to other people using GLP-1 medications, and 41% rated it as “fantastic.”

GLP-1 medications have significantly helped users manage their weight or treatment for diabetes.¹ Kerry mentioned in a recent press release¹ that these medications have caused some negative effects such as digestive discomfort and fatigue that have even caused some users to stop using the drug. Probiotics may be a good option to help with improving digestive health symptoms.

“Gastrointestinal issues are among the main drivers of a reduced quality of life and one of the key reasons consumers abandon weight management treatment with GLP-1 medications,” said Alexandra Boelrijik, global RD&A vice president at Kerry.¹ “Although several products in the marketplace claim to support digestive issues, few have necessarily been evaluated and tested by a consumer population of GLP-1 medication users. This population reported enhanced GI comfort and improved quality of life after consuming BC30 for 4 weeks. BC30 is a highly stable, science-backed formulation, that can be used in a variety of enhanced food and beverages which can fit seamlessly into consumer routines and changing eating habits.”

On June 25, 2025, Kerry will be hosting a webinar called, “Adapting Appetites Part 2: Keep Your GLP-1 Journey on Track." It will cover recent research evidence, BC30’s digestive health benefits for GLP-1 users, the recent consumer perception study, and how food and beverage brands may be a tool for these users. For those interested, click here to register.²

References

1. GLP-1 users report improved quality of life when consuming Kerry Group’s BC30TM probiotic https://www.kerry.com/about/news-and-media/2025/bc30-glp-1-study (accessed Jun 12, 2025).
2. Adapting appetites: Keep your GLP-1 journey on track https://onlinexperiences.com/scripts/Server.nxp?LASCmd=AI%3A4%3BF%3AQS%2110100&ShowUUID=24B795EB-5A46-49DC-AC33-99F56044E999&GroupID=Onyx&AffiliateData=K_PR_Campaign&Referrer=https%3A%2F%2Fwww.kerry.com%2F (accessed Jun 12, 2025).